LUCD

Lucid Diagnostics Inc.$0.90+0.06 (+6.78%)

Prev Close$0.85·MCap$159.6M·P/E—·Vol1.30M·Yield—

▲

Buys (12M)

$245.3K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$245.3K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Lucid Diagnostics Inc. (LUCD) has been exclusively buying, with 1 insider purchase totaling $245.3K and 0 insider sales totaling $0.00. The most recent insider transaction was by Matheis Dennis (director), who purchased $245.3K worth of shares on May 21, 2026. Lucid Diagnostics Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $159.6M.

LUCD Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 21, 2026	Matheis Dennis	director	Buy	245,000	$1.00	$245.3K	1,033,443+31%
Aug 20, 2025	Matheis Dennis	Director	Buy	100,000	$1.02	$101.8K	0
May 20, 2025	Matheis Dennis	Director	Buy	350,000	$1.31	$457.6K	0
Sep 27, 2023	Lapidus Stanley	Director	Sell	29,947	$1.45	$43.5K	131,339
Sep 22, 2023	Lapidus Stanley	Director	Sell	3,917	$1.45	$5.7K	132,051
Sep 22, 2022	Lapidus Stanley	Director	Sell	33,864	$1.70	$57.7K	152,320

LUCD Insider Buying Activity

The following table shows recent insider purchases of Lucid Diagnostics Inc. (LUCD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 21, 2026	Matheis Dennis	director	Buy	245,000	$1.00	$245.3K	1,033,443+31%
Aug 20, 2025	Matheis Dennis	Director	Buy	100,000	$1.02	$101.8K	0
May 20, 2025	Matheis Dennis	Director	Buy	350,000	$1.31	$457.6K	0

LUCD Insider Selling Activity

The following table shows recent insider sales of Lucid Diagnostics Inc. (LUCD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 27, 2023	Lapidus Stanley	Director	Sell	29,947	$1.45	$43.5K	131,339
Sep 22, 2023	Lapidus Stanley	Director	Sell	3,917	$1.45	$5.7K	132,051
Sep 22, 2022	Lapidus Stanley	Director	Sell	33,864	$1.70	$57.7K	152,320